Global Human Prothrombin Complex Market Analysis and Forecast 2024-2030
Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.
According to APO Research, The global Human Prothrombin Complex market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Global Human Prothrombin Complex key players include Octapharma, Shire, CSL, etc. Global top three manufacturers hold a share over 75%.
North America is the largest market, with a share about 45%, followed by Europe, and Asia-Pacific, both have a share about 45 percent.
In terms of product, 500 IU/Vial is the largest segment, with a share over 50%. And in terms of application, the largest application is Hemophilia B, followed by Vitamin K Deficiency, etc.
This report presents an overview of global market for Human Prothrombin Complex, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Human Prothrombin Complex, also provides the sales of main regions and countries. Of the upcoming market potential for Human Prothrombin Complex, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Human Prothrombin Complex sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Human Prothrombin Complex market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Human Prothrombin Complex sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Takeda, CSL, Grifols, Octapharma, Hualan Biological and Meheco Xinxing Pharma, etc.
Human Prothrombin Complex segment by Company
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Prothrombin Complex market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Human Prothrombin Complex and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Prothrombin Complex.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Human Prothrombin Complex in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Human Prothrombin Complex manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Human Prothrombin Complex sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
Chapter 14: The main concluding insights of the report.
According to APO Research, The global Human Prothrombin Complex market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Global Human Prothrombin Complex key players include Octapharma, Shire, CSL, etc. Global top three manufacturers hold a share over 75%.
North America is the largest market, with a share about 45%, followed by Europe, and Asia-Pacific, both have a share about 45 percent.
In terms of product, 500 IU/Vial is the largest segment, with a share over 50%. And in terms of application, the largest application is Hemophilia B, followed by Vitamin K Deficiency, etc.
This report presents an overview of global market for Human Prothrombin Complex, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Human Prothrombin Complex, also provides the sales of main regions and countries. Of the upcoming market potential for Human Prothrombin Complex, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Human Prothrombin Complex sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Human Prothrombin Complex market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Human Prothrombin Complex sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Takeda, CSL, Grifols, Octapharma, Hualan Biological and Meheco Xinxing Pharma, etc.
Human Prothrombin Complex segment by Company
- Takeda
- CSL
- Grifols
- Octapharma
- Hualan Biological
- Meheco Xinxing Pharma
- 500 IU/Vial
- 600 IU/Vial
- 1000 IU/Vial
- Others
- Hemophilia B
- Vitamin K Deficiency
- Others
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Prothrombin Complex market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Human Prothrombin Complex and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Prothrombin Complex.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Human Prothrombin Complex in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Human Prothrombin Complex manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Human Prothrombin Complex sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
Chapter 14: The main concluding insights of the report.
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Human Prothrombin Complex Market by Type
1.2.1 Global Human Prothrombin Complex Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 500 IU/Vial
1.2.3 600 IU/Vial
1.2.4 1000 IU/Vial
1.2.5 Others
1.3 Human Prothrombin Complex Market by Application
1.3.1 Global Human Prothrombin Complex Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Hemophilia B
1.3.3 Vitamin K Deficiency
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 HUMAN PROTHROMBIN COMPLEX MARKET DYNAMICS
2.1 Human Prothrombin Complex Industry Trends
2.2 Human Prothrombin Complex Industry Drivers
2.3 Human Prothrombin Complex Industry Opportunities and Challenges
2.4 Human Prothrombin Complex Industry Restraints
3 GLOBAL MARKET GROWTH PROSPECTS
3.1 Global Human Prothrombin Complex Revenue Estimates and Forecasts (2019-2030)
3.2 Global Human Prothrombin Complex Revenue by Region
3.2.1 Global Human Prothrombin Complex Revenue by Region: 2019 VS 2023 VS 2030
3.2.2 Global Human Prothrombin Complex Revenue by Region (2019-2024)
3.2.3 Global Human Prothrombin Complex Revenue by Region (2025-2030)
3.2.4 Global Human Prothrombin Complex Revenue Market Share by Region (2019-2030)
3.3 Global Human Prothrombin Complex Sales Estimates and Forecasts 2019-2030
3.4 Global Human Prothrombin Complex Sales by Region
3.4.1 Global Human Prothrombin Complex Sales by Region: 2019 VS 2023 VS 2030
3.4.2 Global Human Prothrombin Complex Sales by Region (2019-2024)
3.4.3 Global Human Prothrombin Complex Sales by Region (2025-2030)
3.4.4 Global Human Prothrombin Complex Sales Market Share by Region (2019-2030)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 Middle East, Africa and Latin America
4 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
4.1 Global Human Prothrombin Complex Revenue by Manufacturers
4.1.1 Global Human Prothrombin Complex Revenue by Manufacturers (2019-2024)
4.1.2 Global Human Prothrombin Complex Revenue Market Share by Manufacturers (2019-2024)
4.1.3 Global Human Prothrombin Complex Manufacturers Revenue Share Top 10 and Top 5 in 2023
4.2 Global Human Prothrombin Complex Sales by Manufacturers
4.2.1 Global Human Prothrombin Complex Sales by Manufacturers (2019-2024)
4.2.2 Global Human Prothrombin Complex Sales Market Share by Manufacturers (2019-2024)
4.2.3 Global Human Prothrombin Complex Manufacturers Sales Share Top 10 and Top 5 in 2023
4.3 Global Human Prothrombin Complex Sales Price by Manufacturers (2019-2024)
4.4 Global Human Prothrombin Complex Key Manufacturers Ranking, 2022 VS 2023 VS 2024
4.5 Global Human Prothrombin Complex Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Human Prothrombin Complex Manufacturers, Product Type & Application
4.7 Global Human Prothrombin Complex Manufacturers Commercialization Time
4.8 Market Competitive Analysis
4.8.1 Global Human Prothrombin Complex Market CR5 and HHI
4.8.2 2023 Human Prothrombin Complex Tier 1, Tier 2, and Tier
5 HUMAN PROTHROMBIN COMPLEX MARKET BY TYPE
5.1 Global Human Prothrombin Complex Revenue by Type
5.1.1 Global Human Prothrombin Complex Revenue by Type (2019 VS 2023 VS 2030)
5.1.2 Global Human Prothrombin Complex Revenue by Type (2019-2030) & (US$ Million)
5.1.3 Global Human Prothrombin Complex Revenue Market Share by Type (2019-2030)
5.2 Global Human Prothrombin Complex Sales by Type
5.2.1 Global Human Prothrombin Complex Sales by Type (2019 VS 2023 VS 2030)
5.2.2 Global Human Prothrombin Complex Sales by Type (2019-2030) & (K Units)
5.2.3 Global Human Prothrombin Complex Sales Market Share by Type (2019-2030)
5.3 Global Human Prothrombin Complex Price by Type
6 HUMAN PROTHROMBIN COMPLEX MARKET BY APPLICATION
6.1 Global Human Prothrombin Complex Revenue by Application
6.1.1 Global Human Prothrombin Complex Revenue by Application (2019 VS 2023 VS 2030)
6.1.2 Global Human Prothrombin Complex Revenue by Application (2019-2030) & (US$ Million)
6.1.3 Global Human Prothrombin Complex Revenue Market Share by Application (2019-2030)
6.2 Global Human Prothrombin Complex Sales by Application
6.2.1 Global Human Prothrombin Complex Sales by Application (2019 VS 2023 VS 2030)
6.2.2 Global Human Prothrombin Complex Sales by Application (2019-2030) & (K Units)
6.2.3 Global Human Prothrombin Complex Sales Market Share by Application (2019-2030)
6.3 Global Human Prothrombin Complex Price by Application
7 COMPANY PROFILES
7.1 Takeda
7.1.1 Takeda Comapny Information
7.1.2 Takeda Business Overview
7.1.3 Takeda Human Prothrombin Complex Sales, Revenue, Price and Gross Margin (2019-2024)
7.1.4 Takeda Human Prothrombin Complex Product Portfolio
7.1.5 Takeda Recent Developments
7.2 CSL
7.2.1 CSL Comapny Information
7.2.2 CSL Business Overview
7.2.3 CSL Human Prothrombin Complex Sales, Revenue, Price and Gross Margin (2019-2024)
7.2.4 CSL Human Prothrombin Complex Product Portfolio
7.2.5 CSL Recent Developments
7.3 Grifols
7.3.1 Grifols Comapny Information
7.3.2 Grifols Business Overview
7.3.3 Grifols Human Prothrombin Complex Sales, Revenue, Price and Gross Margin (2019-2024)
7.3.4 Grifols Human Prothrombin Complex Product Portfolio
7.3.5 Grifols Recent Developments
7.4 Octapharma
7.4.1 Octapharma Comapny Information
7.4.2 Octapharma Business Overview
7.4.3 Octapharma Human Prothrombin Complex Sales, Revenue, Price and Gross Margin (2019-2024)
7.4.4 Octapharma Human Prothrombin Complex Product Portfolio
7.4.5 Octapharma Recent Developments
7.5 Hualan Biological
7.5.1 Hualan Biological Comapny Information
7.5.2 Hualan Biological Business Overview
7.5.3 Hualan Biological Human Prothrombin Complex Sales, Revenue, Price and Gross Margin (2019-2024)
7.5.4 Hualan Biological Human Prothrombin Complex Product Portfolio
7.5.5 Hualan Biological Recent Developments
7.6 Meheco Xinxing Pharma
7.6.1 Meheco Xinxing Pharma Comapny Information
7.6.2 Meheco Xinxing Pharma Business Overview
7.6.3 Meheco Xinxing Pharma Human Prothrombin Complex Sales, Revenue, Price and Gross Margin (2019-2024)
7.6.4 Meheco Xinxing Pharma Human Prothrombin Complex Product Portfolio
7.6.5 Meheco Xinxing Pharma Recent Developments
8 NORTH AMERICA
8.1 North America Human Prothrombin Complex Market Size by Type
8.1.1 North America Human Prothrombin Complex Revenue by Type (2019-2030)
8.1.2 North America Human Prothrombin Complex Sales by Type (2019-2030)
8.1.3 North America Human Prothrombin Complex Price by Type (2019-2030)
8.2 North America Human Prothrombin Complex Market Size by Application
8.2.1 North America Human Prothrombin Complex Revenue by Application (2019-2030)
8.2.2 North America Human Prothrombin Complex Sales by Application (2019-2030)
8.2.3 North America Human Prothrombin Complex Price by Application (2019-2030)
8.3 North America Human Prothrombin Complex Market Size by Country
8.3.1 North America Human Prothrombin Complex Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
8.3.2 North America Human Prothrombin Complex Sales by Country (2019 VS 2023 VS 2030)
8.3.3 North America Human Prothrombin Complex Price by Country (2019-2030)
8.3.4 U.S.
8.3.5 Canada
9 EUROPE
9.1 Europe Human Prothrombin Complex Market Size by Type
9.1.1 Europe Human Prothrombin Complex Revenue by Type (2019-2030)
9.1.2 Europe Human Prothrombin Complex Sales by Type (2019-2030)
9.1.3 Europe Human Prothrombin Complex Price by Type (2019-2030)
9.2 Europe Human Prothrombin Complex Market Size by Application
9.2.1 Europe Human Prothrombin Complex Revenue by Application (2019-2030)
9.2.2 Europe Human Prothrombin Complex Sales by Application (2019-2030)
9.2.3 Europe Human Prothrombin Complex Price by Application (2019-2030)
9.3 Europe Human Prothrombin Complex Market Size by Country
9.3.1 Europe Human Prothrombin Complex Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
9.3.2 Europe Human Prothrombin Complex Sales by Country (2019 VS 2023 VS 2030)
9.3.3 Europe Human Prothrombin Complex Price by Country (2019-2030)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Russia
10 CHINA
10.1 China Human Prothrombin Complex Market Size by Type
10.1.1 China Human Prothrombin Complex Revenue by Type (2019-2030)
10.1.2 China Human Prothrombin Complex Sales by Type (2019-2030)
10.1.3 China Human Prothrombin Complex Price by Type (2019-2030)
10.2 China Human Prothrombin Complex Market Size by Application
10.2.1 China Human Prothrombin Complex Revenue by Application (2019-2030)
10.2.2 China Human Prothrombin Complex Sales by Application (2019-2030)
10.2.3 China Human Prothrombin Complex Price by Application (2019-2030)
11 ASIA (EXCLUDING CHINA)
11.1 Asia Human Prothrombin Complex Market Size by Type
11.1.1 Asia Human Prothrombin Complex Revenue by Type (2019-2030)
11.1.2 Asia Human Prothrombin Complex Sales by Type (2019-2030)
11.1.3 Asia Human Prothrombin Complex Price by Type (2019-2030)
11.2 Asia Human Prothrombin Complex Market Size by Application
11.2.1 Asia Human Prothrombin Complex Revenue by Application (2019-2030)
11.2.2 Asia Human Prothrombin Complex Sales by Application (2019-2030)
11.2.3 Asia Human Prothrombin Complex Price by Application (2019-2030)
11.3 Asia Human Prothrombin Complex Market Size by Country
11.3.1 Asia Human Prothrombin Complex Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
11.3.2 Asia Human Prothrombin Complex Sales by Country (2019 VS 2023 VS 2030)
11.3.3 Asia Human Prothrombin Complex Price by Country (2019-2030)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 China Taiwan
11.3.9 Southeast Asia
12 MIDDLE EAST, AFRICA AND LATIN AMERICA
12.1 MEALA Human Prothrombin Complex Market Size by Type
12.1.1 MEALA Human Prothrombin Complex Revenue by Type (2019-2030)
12.1.2 MEALA Human Prothrombin Complex Sales by Type (2019-2030)
12.1.3 MEALA Human Prothrombin Complex Price by Type (2019-2030)
12.2 MEALA Human Prothrombin Complex Market Size by Application
12.2.1 MEALA Human Prothrombin Complex Revenue by Application (2019-2030)
12.2.2 MEALA Human Prothrombin Complex Sales by Application (2019-2030)
12.2.3 MEALA Human Prothrombin Complex Price by Application (2019-2030)
12.3 MEALA Human Prothrombin Complex Market Size by Country
12.3.1 MEALA Human Prothrombin Complex Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
12.3.2 MEALA Human Prothrombin Complex Sales by Country (2019 VS 2023 VS 2030)
12.3.3 MEALA Human Prothrombin Complex Price by Country (2019-2030)
12.3.4 Mexico
12.3.5 Brazil
12.3.6 Israel
12.3.7 Argentina
12.3.8 Colombia
12.3.9 Turkey
12.3.10 Saudi Arabia
12.3.11 UAE
13 VALUE CHAIN AND SALES CHANNELS ANALYSIS
13.1 Human Prothrombin Complex Value Chain Analysis
13.1.1 Human Prothrombin Complex Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Human Prothrombin Complex Production Mode & Process
13.2 Human Prothrombin Complex Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Human Prothrombin Complex Distributors
13.2.3 Human Prothrombin Complex Customers
14 CONCLUDING INSIGHTS
15 APPENDIX
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer
1.1 Product Definition
1.2 Human Prothrombin Complex Market by Type
1.2.1 Global Human Prothrombin Complex Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 500 IU/Vial
1.2.3 600 IU/Vial
1.2.4 1000 IU/Vial
1.2.5 Others
1.3 Human Prothrombin Complex Market by Application
1.3.1 Global Human Prothrombin Complex Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Hemophilia B
1.3.3 Vitamin K Deficiency
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 HUMAN PROTHROMBIN COMPLEX MARKET DYNAMICS
2.1 Human Prothrombin Complex Industry Trends
2.2 Human Prothrombin Complex Industry Drivers
2.3 Human Prothrombin Complex Industry Opportunities and Challenges
2.4 Human Prothrombin Complex Industry Restraints
3 GLOBAL MARKET GROWTH PROSPECTS
3.1 Global Human Prothrombin Complex Revenue Estimates and Forecasts (2019-2030)
3.2 Global Human Prothrombin Complex Revenue by Region
3.2.1 Global Human Prothrombin Complex Revenue by Region: 2019 VS 2023 VS 2030
3.2.2 Global Human Prothrombin Complex Revenue by Region (2019-2024)
3.2.3 Global Human Prothrombin Complex Revenue by Region (2025-2030)
3.2.4 Global Human Prothrombin Complex Revenue Market Share by Region (2019-2030)
3.3 Global Human Prothrombin Complex Sales Estimates and Forecasts 2019-2030
3.4 Global Human Prothrombin Complex Sales by Region
3.4.1 Global Human Prothrombin Complex Sales by Region: 2019 VS 2023 VS 2030
3.4.2 Global Human Prothrombin Complex Sales by Region (2019-2024)
3.4.3 Global Human Prothrombin Complex Sales by Region (2025-2030)
3.4.4 Global Human Prothrombin Complex Sales Market Share by Region (2019-2030)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 Middle East, Africa and Latin America
4 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
4.1 Global Human Prothrombin Complex Revenue by Manufacturers
4.1.1 Global Human Prothrombin Complex Revenue by Manufacturers (2019-2024)
4.1.2 Global Human Prothrombin Complex Revenue Market Share by Manufacturers (2019-2024)
4.1.3 Global Human Prothrombin Complex Manufacturers Revenue Share Top 10 and Top 5 in 2023
4.2 Global Human Prothrombin Complex Sales by Manufacturers
4.2.1 Global Human Prothrombin Complex Sales by Manufacturers (2019-2024)
4.2.2 Global Human Prothrombin Complex Sales Market Share by Manufacturers (2019-2024)
4.2.3 Global Human Prothrombin Complex Manufacturers Sales Share Top 10 and Top 5 in 2023
4.3 Global Human Prothrombin Complex Sales Price by Manufacturers (2019-2024)
4.4 Global Human Prothrombin Complex Key Manufacturers Ranking, 2022 VS 2023 VS 2024
4.5 Global Human Prothrombin Complex Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Human Prothrombin Complex Manufacturers, Product Type & Application
4.7 Global Human Prothrombin Complex Manufacturers Commercialization Time
4.8 Market Competitive Analysis
4.8.1 Global Human Prothrombin Complex Market CR5 and HHI
4.8.2 2023 Human Prothrombin Complex Tier 1, Tier 2, and Tier
5 HUMAN PROTHROMBIN COMPLEX MARKET BY TYPE
5.1 Global Human Prothrombin Complex Revenue by Type
5.1.1 Global Human Prothrombin Complex Revenue by Type (2019 VS 2023 VS 2030)
5.1.2 Global Human Prothrombin Complex Revenue by Type (2019-2030) & (US$ Million)
5.1.3 Global Human Prothrombin Complex Revenue Market Share by Type (2019-2030)
5.2 Global Human Prothrombin Complex Sales by Type
5.2.1 Global Human Prothrombin Complex Sales by Type (2019 VS 2023 VS 2030)
5.2.2 Global Human Prothrombin Complex Sales by Type (2019-2030) & (K Units)
5.2.3 Global Human Prothrombin Complex Sales Market Share by Type (2019-2030)
5.3 Global Human Prothrombin Complex Price by Type
6 HUMAN PROTHROMBIN COMPLEX MARKET BY APPLICATION
6.1 Global Human Prothrombin Complex Revenue by Application
6.1.1 Global Human Prothrombin Complex Revenue by Application (2019 VS 2023 VS 2030)
6.1.2 Global Human Prothrombin Complex Revenue by Application (2019-2030) & (US$ Million)
6.1.3 Global Human Prothrombin Complex Revenue Market Share by Application (2019-2030)
6.2 Global Human Prothrombin Complex Sales by Application
6.2.1 Global Human Prothrombin Complex Sales by Application (2019 VS 2023 VS 2030)
6.2.2 Global Human Prothrombin Complex Sales by Application (2019-2030) & (K Units)
6.2.3 Global Human Prothrombin Complex Sales Market Share by Application (2019-2030)
6.3 Global Human Prothrombin Complex Price by Application
7 COMPANY PROFILES
7.1 Takeda
7.1.1 Takeda Comapny Information
7.1.2 Takeda Business Overview
7.1.3 Takeda Human Prothrombin Complex Sales, Revenue, Price and Gross Margin (2019-2024)
7.1.4 Takeda Human Prothrombin Complex Product Portfolio
7.1.5 Takeda Recent Developments
7.2 CSL
7.2.1 CSL Comapny Information
7.2.2 CSL Business Overview
7.2.3 CSL Human Prothrombin Complex Sales, Revenue, Price and Gross Margin (2019-2024)
7.2.4 CSL Human Prothrombin Complex Product Portfolio
7.2.5 CSL Recent Developments
7.3 Grifols
7.3.1 Grifols Comapny Information
7.3.2 Grifols Business Overview
7.3.3 Grifols Human Prothrombin Complex Sales, Revenue, Price and Gross Margin (2019-2024)
7.3.4 Grifols Human Prothrombin Complex Product Portfolio
7.3.5 Grifols Recent Developments
7.4 Octapharma
7.4.1 Octapharma Comapny Information
7.4.2 Octapharma Business Overview
7.4.3 Octapharma Human Prothrombin Complex Sales, Revenue, Price and Gross Margin (2019-2024)
7.4.4 Octapharma Human Prothrombin Complex Product Portfolio
7.4.5 Octapharma Recent Developments
7.5 Hualan Biological
7.5.1 Hualan Biological Comapny Information
7.5.2 Hualan Biological Business Overview
7.5.3 Hualan Biological Human Prothrombin Complex Sales, Revenue, Price and Gross Margin (2019-2024)
7.5.4 Hualan Biological Human Prothrombin Complex Product Portfolio
7.5.5 Hualan Biological Recent Developments
7.6 Meheco Xinxing Pharma
7.6.1 Meheco Xinxing Pharma Comapny Information
7.6.2 Meheco Xinxing Pharma Business Overview
7.6.3 Meheco Xinxing Pharma Human Prothrombin Complex Sales, Revenue, Price and Gross Margin (2019-2024)
7.6.4 Meheco Xinxing Pharma Human Prothrombin Complex Product Portfolio
7.6.5 Meheco Xinxing Pharma Recent Developments
8 NORTH AMERICA
8.1 North America Human Prothrombin Complex Market Size by Type
8.1.1 North America Human Prothrombin Complex Revenue by Type (2019-2030)
8.1.2 North America Human Prothrombin Complex Sales by Type (2019-2030)
8.1.3 North America Human Prothrombin Complex Price by Type (2019-2030)
8.2 North America Human Prothrombin Complex Market Size by Application
8.2.1 North America Human Prothrombin Complex Revenue by Application (2019-2030)
8.2.2 North America Human Prothrombin Complex Sales by Application (2019-2030)
8.2.3 North America Human Prothrombin Complex Price by Application (2019-2030)
8.3 North America Human Prothrombin Complex Market Size by Country
8.3.1 North America Human Prothrombin Complex Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
8.3.2 North America Human Prothrombin Complex Sales by Country (2019 VS 2023 VS 2030)
8.3.3 North America Human Prothrombin Complex Price by Country (2019-2030)
8.3.4 U.S.
8.3.5 Canada
9 EUROPE
9.1 Europe Human Prothrombin Complex Market Size by Type
9.1.1 Europe Human Prothrombin Complex Revenue by Type (2019-2030)
9.1.2 Europe Human Prothrombin Complex Sales by Type (2019-2030)
9.1.3 Europe Human Prothrombin Complex Price by Type (2019-2030)
9.2 Europe Human Prothrombin Complex Market Size by Application
9.2.1 Europe Human Prothrombin Complex Revenue by Application (2019-2030)
9.2.2 Europe Human Prothrombin Complex Sales by Application (2019-2030)
9.2.3 Europe Human Prothrombin Complex Price by Application (2019-2030)
9.3 Europe Human Prothrombin Complex Market Size by Country
9.3.1 Europe Human Prothrombin Complex Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
9.3.2 Europe Human Prothrombin Complex Sales by Country (2019 VS 2023 VS 2030)
9.3.3 Europe Human Prothrombin Complex Price by Country (2019-2030)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Russia
10 CHINA
10.1 China Human Prothrombin Complex Market Size by Type
10.1.1 China Human Prothrombin Complex Revenue by Type (2019-2030)
10.1.2 China Human Prothrombin Complex Sales by Type (2019-2030)
10.1.3 China Human Prothrombin Complex Price by Type (2019-2030)
10.2 China Human Prothrombin Complex Market Size by Application
10.2.1 China Human Prothrombin Complex Revenue by Application (2019-2030)
10.2.2 China Human Prothrombin Complex Sales by Application (2019-2030)
10.2.3 China Human Prothrombin Complex Price by Application (2019-2030)
11 ASIA (EXCLUDING CHINA)
11.1 Asia Human Prothrombin Complex Market Size by Type
11.1.1 Asia Human Prothrombin Complex Revenue by Type (2019-2030)
11.1.2 Asia Human Prothrombin Complex Sales by Type (2019-2030)
11.1.3 Asia Human Prothrombin Complex Price by Type (2019-2030)
11.2 Asia Human Prothrombin Complex Market Size by Application
11.2.1 Asia Human Prothrombin Complex Revenue by Application (2019-2030)
11.2.2 Asia Human Prothrombin Complex Sales by Application (2019-2030)
11.2.3 Asia Human Prothrombin Complex Price by Application (2019-2030)
11.3 Asia Human Prothrombin Complex Market Size by Country
11.3.1 Asia Human Prothrombin Complex Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
11.3.2 Asia Human Prothrombin Complex Sales by Country (2019 VS 2023 VS 2030)
11.3.3 Asia Human Prothrombin Complex Price by Country (2019-2030)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 China Taiwan
11.3.9 Southeast Asia
12 MIDDLE EAST, AFRICA AND LATIN AMERICA
12.1 MEALA Human Prothrombin Complex Market Size by Type
12.1.1 MEALA Human Prothrombin Complex Revenue by Type (2019-2030)
12.1.2 MEALA Human Prothrombin Complex Sales by Type (2019-2030)
12.1.3 MEALA Human Prothrombin Complex Price by Type (2019-2030)
12.2 MEALA Human Prothrombin Complex Market Size by Application
12.2.1 MEALA Human Prothrombin Complex Revenue by Application (2019-2030)
12.2.2 MEALA Human Prothrombin Complex Sales by Application (2019-2030)
12.2.3 MEALA Human Prothrombin Complex Price by Application (2019-2030)
12.3 MEALA Human Prothrombin Complex Market Size by Country
12.3.1 MEALA Human Prothrombin Complex Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
12.3.2 MEALA Human Prothrombin Complex Sales by Country (2019 VS 2023 VS 2030)
12.3.3 MEALA Human Prothrombin Complex Price by Country (2019-2030)
12.3.4 Mexico
12.3.5 Brazil
12.3.6 Israel
12.3.7 Argentina
12.3.8 Colombia
12.3.9 Turkey
12.3.10 Saudi Arabia
12.3.11 UAE
13 VALUE CHAIN AND SALES CHANNELS ANALYSIS
13.1 Human Prothrombin Complex Value Chain Analysis
13.1.1 Human Prothrombin Complex Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Human Prothrombin Complex Production Mode & Process
13.2 Human Prothrombin Complex Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Human Prothrombin Complex Distributors
13.2.3 Human Prothrombin Complex Customers
14 CONCLUDING INSIGHTS
15 APPENDIX
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer
